Non- Applicability of Annual Secretarial Compliance Report for the year ended 31st March 2025 under Regulation 24A
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Boston Bio Systems Limited has informed BSE that it is exempt from filing the Annual Secretarial Compliance Report under SEBI Regulation 24A for the financial year ended 31 March 2025. The exemption applies because the company's paid-up equity share capital (₹7.00 crore) and net worth (₹6.45 crore) as on 31 March 2024 are both below the SEBI thresholds of ₹10 crore and ₹25 crore, respectively. As a small-cap listed entity falling under Regulation 15(2)(b), several corporate governance compliance requirements, including the annual secretarial report, do not apply to it. The company has undertaken to comply with these regulations within six months if it ever crosses the threshold limits in the future.
This is a routine, neutral filing with no material impact on shareholders or stock price. It simply confirms the company's small size qualifies it for reduced regulatory compliance, and investors should note the company is a micro-cap entity on BSE.